Free Trial

Lexicon Pharmaceuticals (LXRX) SEC Filings & 10K Form

Lexicon Pharmaceuticals logo
$0.66 +0.05 (+7.56%)
Closing price 05/22/2025 04:00 PM Eastern
Extended Trading
$0.64 -0.02 (-2.73%)
As of 04:21 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Lexicon Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/14/2025
6:08 AM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
4:48 PM
DEBBANE RAYMOND (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:49 PM
Amouyal Philippe (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:50 PM
BARKER SAM L (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:50 PM
Lexicon Pharmaceuticals (Issuer)
SOBECKI CHRISTOPHER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:51 PM
Lexicon Pharmaceuticals (Issuer)
Sullivan Diane E. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2025
4:52 PM
Lexicon Pharmaceuticals (Issuer)
Swain Judith L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2025
6:11 AM
Lexicon Pharmaceuticals (Filer)
Form ARS
04/22/2025
6:07 AM
Lexicon Pharmaceuticals (Filer)
Form DEF 14A
04/22/2025
6:09 AM
Lexicon Pharmaceuticals (Filer)
Form DEFA14A
03/28/2025
6:59 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
3:31 PM
Granowitz Craig B (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:32 PM
Lexicon Pharmaceuticals (Issuer)
MAIN ALAN J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:33 PM
Lexicon Pharmaceuticals (Issuer)
McDermott Wendy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:33 PM
Alexander Kristen (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:08 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:04 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
3:06 PM
Coiante Scott M (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/16/2024
6:00 PM
Artal Participations S.a r.l. (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
8:33 PM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
12/02/2024
4:40 PM
Cheung Ivan (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/02/2024
4:41 PM
Cheung Ivan (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2024
3:05 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
3:26 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
6:12 AM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/16/2024
3:37 PM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
3:58 PM
DeFrancesco Lisa (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/16/2024
5:51 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
11:15 PM
Lexicon Pharmaceuticals (Filer)
Form EFFECT
08/15/2024
3:47 PM
COATS LONNEL (Reporting)
Lexicon Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
7:39 AM
Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
7:40 AM
Corrigan Brian (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
8:37 AM
Lexicon Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/02/2024
6:06 AM
Lexicon Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2024
4:44 PM
Invus, L.P. (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13D/A
07/29/2024
4:31 PM
Invus Global Management, LLC (Reporting)
Lexicon Pharmaceuticals (Issuer)
Siren, L.L.C. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
9:10 AM
FMR LLC (Filed by)
Lexicon Pharmaceuticals (Subject)
Form SC 13G
07/08/2024
4:26 PM
Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/08/2024
4:27 PM
Exton Michael (Reporting)
Lexicon Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:27 PM
Lexicon Pharmaceuticals (Issuer)
WADE JEFFREY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
8:15 AM
Lexicon Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon just did WHAT!? (Ad)

As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.

Click here to see how to claim your stake before they launch to avoid missing out.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LXRX) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners